ELVN
Price
$18.89
Change
-$0.79 (-4.01%)
Updated
Apr 1, 04:59 PM (EDT)
Capitalization
964.41M
36 days until earnings call
ERAS
Price
$1.21
Change
-$0.16 (-11.68%)
Updated
Apr 1 closing price
Capitalization
386.66M
36 days until earnings call
Ad is loading...

ELVN vs ERAS

Header iconELVN vs ERAS Comparison
Open Charts ELVN vs ERASBanner chart's image
Enliven Therapeutics
Price$18.89
Change-$0.79 (-4.01%)
Volume$4.69K
Capitalization964.41M
Erasca
Price$1.21
Change-$0.16 (-11.68%)
Volume$2.04M
Capitalization386.66M
ELVN vs ERAS Comparison Chart
Loading...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ERAS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELVN vs. ERAS commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELVN is a StrongBuy and ERAS is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (ELVN: $19.68 vs. ERAS: $1.37)
Brand notoriety: ELVN and ERAS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELVN: 254% vs. ERAS: 170%
Market capitalization -- ELVN: $964.41M vs. ERAS: $386.66M
ELVN [@Biotechnology] is valued at $964.41M. ERAS’s [@Biotechnology] market capitalization is $386.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELVN’s FA Score shows that 0 FA rating(s) are green whileERAS’s FA Score has 1 green FA rating(s).

  • ELVN’s FA Score: 0 green, 5 red.
  • ERAS’s FA Score: 1 green, 4 red.
According to our system of comparison, both ELVN and ERAS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELVN’s TA Score shows that 2 TA indicator(s) are bullish while ERAS’s TA Score has 4 bullish TA indicator(s).

  • ELVN’s TA Score: 2 bullish, 6 bearish.
  • ERAS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ERAS is a better buy in the short-term than ELVN.

Price Growth

ELVN (@Biotechnology) experienced а -12.38% price change this week, while ERAS (@Biotechnology) price change was -8.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.07%. For the same industry, the average monthly price growth was -13.26%, and the average quarterly price growth was -12.25%.

Reported Earning Dates

ELVN is expected to report earnings on May 08, 2025.

ERAS is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-9.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELVN($964M) has a higher market cap than ERAS($387M). ELVN YTD gains are higher at: -12.533 vs. ERAS (-45.418). ELVN has higher annual earnings (EBITDA): -104.24M vs. ERAS (-151.33M). ERAS (319M) and ELVN (313M) have equal amount of cash in the bank . ELVN has less debt than ERAS: ELVN (0) vs ERAS (52.9M). ELVN (0) and ERAS (0) have equivalent revenues.
ELVNERASELVN / ERAS
Capitalization964M387M249%
EBITDA-104.24M-151.33M69%
Gain YTD-12.533-45.41828%
P/E RatioN/AN/A-
Revenue00-
Total Cash313M319M98%
Total Debt052.9M-
TECHNICAL ANALYSIS
Technical Analysis
ELVNERAS
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 9 days ago
82%
Bullish Trend 28 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ERAS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
QIBGX21.210.04
+0.19%
Federated Hermes MDT Balanced IS
EISMX39.42N/A
N/A
Eaton Vance Atlanta Capital SMID-Cap I
IARCX16.83N/A
N/A
Invesco Real Estate C
UIGRX34.63N/A
N/A
Victory Growth Institutional
JOMEX12.59N/A
N/A
JOHCM Emerging Mkts Discovery Advisor

ELVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with APGE. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then APGE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVN
1D Price
Change %
ELVN100%
-6.60%
APGE - ELVN
46%
Loosely correlated
-5.94%
DNLI - ELVN
45%
Loosely correlated
-8.02%
CRNX - ELVN
44%
Loosely correlated
-3.43%
ERAS - ELVN
43%
Loosely correlated
-9.87%
ABOS - ELVN
42%
Loosely correlated
-7.56%
More